ADVANCE PROGRAMME CALL FOR ABSTRACTS

www.idf.org/congress TABLE OF CONTENTS

Welcome to the IDF Congress 2017 3 International Diabetes Federation Welcome to 4 Congress committees 5 The International Diabetes Federation (IDF) is an umbrella organisation of over Key dates 7 230 national diabetes associations in 170 countries and territories. It represents Congress-at-a-glance 8 the interests of the growing number of people with diabetes and those at risk. The Why attend the IDF Congress 2017? 9 Federation has been leading the global diabetes community since 1950. Programme committee 10 Learning objectives 14 IDF is a diverse and inclusive multi-cultural network of national diabetes associations Programme preview 16 and an authoritative global voice in non-communicable diseases. Programme topic overview 18 Call for abstracts 24 The Federation’s activities aim to influence policy, increase public awareness and Registration 28 encourage health improvement, promote the exchange of high-quality information Accommodation 30 about diabetes, and provide education for people with diabetes and their healthcare Travel and visa 34 providers. IDF is associated with the Department of Public Information of the United Contact 36 Nations and is in official relations with the World Health Organization (WHO) and IDF 2017: a healthy congress 37 the Pan American Health Organization (PAHO). For more information please visit www.idf.org

IDF | Promoting diabetes care, prevention and a cure worldwide Please note, information in the the Advance Programme is subject to change.

1 It gives me great pleasure to invite you to attend the IDF Congress WELCOME TO 2017 in Abu Dhabi, .

The 2017 congress marks a welcome return to the United Arab THE IDF CONGRESS Emirates following the very successful edition held in Dubai in 2011. Diabetes continues to have a significant impact in the Middle East 2017 and North Africa region with one in ten adults living with diabetes in 2015. Over the past three decades progressive urbanisation, increased life expectancy and economic development associated with a shift to unhealthy lifestyles have resulted in a huge explosion in type 2 diabetes. The UAE is particularly affected with one in five people currently living with diabetes.

With the number of people with diabetes in the region expected to more than double within the next twenty years, Abu Dhabi is the perfect location to bring together the extensive global network of physicians, scientists, nurses, educators, other healthcare professionals, government officials, policy makers and diabetes associations that IDF represents. The IDF Congress will continue to provide a unique forum for knowledge exchange and sharing of best practice in diabetes prevention, education and treatment, helping to foster the collaborations, connections and political breakthroughs that are required to improve the lives of people living with diabetes, help protect those at risk and reduce the impact of diabetes on our societies.

I look forward to welcoming you in Abu Dhabi to help shape the future of diabetes through a strong and united voice.

Dr Shaukat Sadikot President, International Diabetes Federation

2 3 CONGRESS COMMITTEES On behalf of the Organising, Programme and National Advisory Committees, we are delighted to welcome you to the IDF Congress 2017 in Abu Dhabi, UAE. Organising Committee IDF’s biennial congress is the most significant global diabetes event, convening the international diabetes community through its vibrant and diverse scientific programme, satellite symposia, exhibition and global village, showcasing the membership of IDF of • Monira Al Arouj Kuwait Chair over 230 national associations and societies in 170 countries. • Abdulrazzaq Al Madani UAE Member • Abdullah Ben Nakhi Kuwait Member Abu Dhabi, the capital of the United Arab Emirates, a destination where the • Nam Cho Korea Member Welcome to past is preserved, cherished and respected while the future is meticulously • Linong Ji Member planned and considered, will host a scientific programme comprised of nine • Banshi Saboo Member streams, introducing new areas such as diabetes and disasters, diabetes Abu Dhabi in women and children and diabetes in society and culture. Building on National Advisory Committee the experiences gained from past congresses, IDF 2017 will feature more e-poster presentations, shorter session formats and overflow capacities in every session hall. All improvements intended to maximise • Abdulrazzaq Al Madani UAE Chair the congress experience for all participants. • Mubarak Hamad Al Shamsi UAE Member • Lindsay Fraser UAE Member The venue’s state of the art facilities, modern infrastructure and top level service will provide the ideal setting for delegates to share • Khalid Al Jaberi UAE Member the latest scientific advances in the field, learn from each other’s expertise and experience, and develop strategies for national, • Fatheya Al Awadi UAE Member regional and global efforts to advance diabetes treatment, improve the lives of people with diabetes and prevent the continued rise • Juma Al Kaabi UAE Member of the epidemic. • Khalifa Al Qubaisi UAE Member • Salem Al Marzouqi UAE Member We look forward to welcoming you to an exceptional congress, which we hope will have a lasting legacy for all involved. • Bakhit Al Kathiri UAE Member • Jamal Al Khateri UAE Member • Mzyed Al Otaibi UAE Member • Ateeq Al Mazrouei UAE Member

Programme Committee Dr Monira Al Arouj Professor Nam Cho Dr Abdulrazzaq Al Madani Chair, Organising Committee Chair, Programme Committee Chair, National Advisory Committee • Nam Cho Korea Chair

4 5 Streams KEY DATES Diabetes in Women and Children Basic and Clinical Science • Hak Chul Jang Korea Lead • Kyong Soo Park Korea Lead • Moshe Hod Deputy • Raimund Weitgasser Deputy • Catherine Kim USA Member Registration • Young-Bum Kim USA Member • Ronald Ma Hong Kong, China Member • Ahmed Reja Ethiopia Member • 2 January 2017 - Online registration opens • Michael Roden Member Education and Integrated Care • Susumu Seino Member • Edwin Fisher USA Lead • 18 August 2017 - Early-rate deadline • Cees Tack The Member • Anil Bhoraskar India Deputy • Felix Assah Cameroon Member • 13 November 2017 - Online registration closes Science of Diabetic Complications • Adriana Forti Member • Isaac Sinay Lead • Zilin Sun China Member • Kamil Salamah Deputy • Larry Distiller Member Epidemiology and Public Health • Ramon Gomis Member • Jaakko Tuomilehto Lead • Soo Lim Korea Deputy Diabetes and Disasters • Helen Colhoun Member • Nizar Albache Syria Lead • Rafael Gabriel Spain Member • Sidartawan Soegondo Deputy • Edward Gregg USA Member • Abdul Basit Member • Naomi Levitt South Africa Member Abstracts & Grants • Manuel Vera Gonzalez Cuba Member Living with Diabetes • 1 February 2017 - Abstract submission Diabetic Foot • Manny Hernandez USA Lead and grant application open • Lawrence Harkless USA Lead • Renza Scibilia Deputy • Ammar Ibraham Deputy • Hakeem Adejumo Nigeria Member • 21 April 2017 - Abstract submission closes • Norina Alinta Gavan Romania Member • Kelly Close USA Member • Crystal Holmes USA Member • Mary Shi China Member • 28 April 2017 - Grant application closes

Diabetes in Society and Culture • Mid-July 2017 - Abstract selection notification • Massimo Massi Benedetti Lead • Early-August 2017 - Grant application notification • Predrag Djordjevic Deputy • Fatheya Al Awadi UAE Member • Edwin Jiménez Member

Scientific programme • June 2017 - Fully searchable scientific programme online • October 2017 - Congress app goes live

6 7 CONGRESS-AT-A-GLANCE WHY ATTEND THE IDF CONGRESS 2017? Monday 4 Dec Tuesday 5 Dec Wednesday 6 Dec Thursday 7 Dec Friday 8 Dec

08.00 Scientific Scientific Scientific Scientific Sessions Sessions Sessions Sessions 09.30 Learn 10.00 • 160 hours of scientific sessions Scientific Scientific Scientific Scientific Sessions Sessions Sessions Sessions • Over 1000 posters 11.30 Satellite 11.45 • CME credits to advance your learning Symposia Posters E Posters E Posters E Meet the x x x Satellite Symposia h Satellite Symposia h Satellite Symposia h Speakers 12.45 i i i b b b 13.15 i i i Scientific t Scientific t Scientific t Scientific Sessions i Sessions i Sessions i Sessions o o o 14.45 n n n Discover 15.15 • Cutting-edge science Scientific Scientific Scientific 16.00 Sessions Sessions Sessions • 9 programme streams 16.45 • 70 international exhibitors

17.00 17.30 18.00 Satellite Satellite Satellite Symposia Symposia Symposia 19.30 Opening Connect 5K@IDF Farewell Evening • 250 speakers • 12 000 delegates • 230 IDF members

8 9 PROGRAMME COMMITTEE

Programme Chair Stream Lead, Science of Diabetic Complications Stream Lead, Diabetes in Society and Culture influential research projects. Among the topics he has researched are Professor Nam Cho currently resides in Dr Isaac Sinay is an advisor at the Dr Massimo Massi Benedetti is former chronic disease prevention, management and quality of life, asthma, the Republic of Korea and is the President- diabetes unit at the Cardiovascular Institute Associate Professor of Endocrinology at the cancer, cardiovascular disease, smoking and weight management. Elect of the International Diabetes of Buenos Aires in Buenos Aires, Argentina. University of Perugia (I), Co-Director of the Federation. Professor Cho is a world He is a member and former president of the WHO Collaborating Centre for Quality Stream Lead, Epidemiology and Public Health renowned diabetes epidemiologist. He was “Sociedad Argentina de Diabetes” and of Development in Diabetes, Scientific Director Professor Jaakko Tuomilehto is a medical faculty at North-western the “Sociedad Argentina de Endocrinologia of the Dasman Diabetes Centre in Kuwait, Professor Emeritus of Public Health, University Medical School until he was y Metabolismo”. He was a principal Former President of IDF Europe and IDF University of Helsinki, Finland, and currently recruited by the Korean government’s investigator for more than 20 clinical trials Vice-President. He is also a member and working as the Chief Scientific Officer at “Korean national brain pool recruitment (phases II, III and IV) and has authored leader of various EU research projects. At Dasman Diabetes Institute in Kuwait. His project” in 1994. He has published over 200 peer reviewed papers on more than 50 scientific publications in the field of diabetes and present, he is President and Scientific Director of the Hub for research interests include the epidemiology type 1 diabetes, type 2 diabetes and gestational diabetes. Professor endocrinology. International Health Research-HIRS. and prevention of diabetes. He has Cho has served as Chairman of the Department of Preventive contributed to many landmark studies, the Medicine at Ajou University School of Medicine and is a Director of Stream Lead, Diabetes and Disasters Stream Lead, Diabetes in Women and Children Finnish Diabetes Prevention Study and the Clinical Epidemiology at the university’s hospital. Since 2000, he has Dr Nizar Al Bache from Syria is the Chair Dr Hak Chul Jang works in the WHO DIAMOND study mapping the incidence of childhood-onset type served as the president of a humanitarian medical NGO, which of the Middle East and North Africa (MENA) Department of Internal Medicine at Seoul 1 diabetes. He currently serves as the Editor-in-Chief of Primary Care provides medical services to under-developed countries. In 2015 he Region of the International Diabetes National University Bundang Hospital and Diabetes. He has contributed to over 1600 peer-reviewed publications received an insignia from the King of Cambodia for 15 years of Federation for 2016-17. He has over 30 Seoul National University College of and has h-index 159. unselfish humanitarian medical services and the construction of a years of experience in the management of Medicine. Professor Jang’s research focuses National Diabetes Centre. type 1 and type 2 diabetes and endocrine on the clinical epidemiological study of Stream Lead, Living with Diabetes diseases. Dr Al Bache was a medical doctor gestational diabetes mellitus, the long-term Mr Manny Hernandez was born in Stream Lead, Basic and Clinical Science at the Aleppo University Hospital and in a follow-up study of women with gestational Venezuela and is living in the San Francisco Professor Kyong Soo Park is a Professor private endocrine and diabetes centre in diabetes mellitus, insulin resistance and Bay Area and has lived with diabetes since of Internal Medicine in the Division of Syria from 1985 to 2012. He has also been Assistant Professor beta-cell function in high risk population, sarcopenia and sarcopenic 2002. As an advocate, he co-founded the Endocrinology and Metabolism at Seoul teaching diabetes and endocrine diseases at the Faculty of Medicine, obesity and U-healthcare in diabetes care. Diabetes Hands Foundation in 2008 and led National University College of Medicine. Aleppo University. the organisation until 2015. Since then he Professor Park’s research focuses on the Stream Lead, Education and Integrated Care has been a part of the executive team at genetics of type 2 diabetes mellitus and the Stream Lead, Diabetic Foot Dr Edwin Fisher is a public health Livongo Health. Manny believes that nobody mechanism of insulin resistance in skeletal Dr Lawrence Harkless is Founding Dean professional, noted researcher and clinical living with diabetes should ever feel alone. muscle. of the College of Podiatric Medicine and psychologist. He also is a former chair of the Professor of Podiatric Medicine, Surgery and Department of Health Behaviour at the Biomechanics at the Western University of Gillings School of Global Public Health. Dr Health Sciences. He has educated thousands Fisher has wide-ranging research interests. of students, residents, physicians and He serves as Global Director of Peers for healthcare providers about the complexities Progress, a program that documents the of diabetic foot complications and the benefits of peer support in diabetes importance of preventative foot care for management and conducts diverse activities to promote peer support people with diabetes as well as operating his own private practice. around the world. Over his career, Dr Fisher has led multiple large and

10 11 12 13 LEARNING OBJECTIVES

Basic and Clinical Science Diabetes and Disasters Diabetes in Society and Culture • Understand that HIP is associated with a higher incidence of maternal mortality, maternal morbidity, perinatal and neonatal Description Description Description morbidity and long-term consequences for both mother and child This stream deals with recent progress in both basic and clinical This new stream will present experiences with dealing with diabetes This stream will deal with all aspects of the diabetes epidemic in • Understand that pregnancy offers a window of opportunity to diabetes research and also presents the latest advances in clinical and disasters, both natural and man-made, and provide practical different societies and how these societies can help with prevention establish services, improve health and prevent intergenerational practice and their application in diabetes care. information on how to be prepared to help people with diabetes and management. transmission of non-communicable diseases before and during disasters. • Take the evidence and underpinnings of current clinical research Learning Objectives Learning Objectives and be able to apply them to the interpretation of clinical data After attending a session in the Basic and Clinical Science stream the Learning Objectives After attending a session in the Diabetes in Society and Culture • Apply the advanced evidence-based research regarding HIP to participant will be able to: After attending a session in the Diabetes and Disasters stream the stream the participant will be able to: clinical practice • Understand some of the latest advances in basic research related to participant will be able to: • Better understand the complexity of real life interventions for the pathogenesis and treatment of diabetes mellitus • Evaluate the possible risks for people with diabetes and healthcare primary and secondary prevention and chronic care management Education and Integrated Care • Understand recent advances in clinical research as well as clinical providers during disasters of diabetes practice in the real world • Plan practical steps to help people with diabetes before and during • Define how environmental and cultural factors influence the Description • Take the evidence and underpinnings of current clinical research disasters management of diabetes and the life of people with diabetes This stream includes the latest developments in diabetes education and be able to apply them to the interpretation of clinical data • Cooperate and coordinate with NGOs and other organisations • Identify roles and responsibilities for improving the life of people and care and their application and integration through healthcare • Apply the most up-to-date evidence-based research to clinical working in the humanitarian field with diabetes according to opportunities and barriers present in professionals, families and communities. practice different societies and cultures Diabetic Foot Learning Objectives Science of Diabetic Complications Diabetes in Women and Children After attending a session in the Education and Integrated Care stream Description the participant will be able to: Description This stream deals with the basic and clinical science of diabetic foot Description • Describe how people with diabetes effectively manage their own This stream deals with the basic and clinical science of diabetic as well as the epidemiology and public health challenges presented This stream will focus on all aspects of hyperglycaemia in pregnancy care and the role healthcare professionals play in supporting this complications, the latest research into these complications and up-to- by the condition. It also focuses on education and care needed for including gestational diabetes and pregnancy in people with diabetes. • Develop improved training for multidisciplinary healthcare providers date prevention politics and treatments. management and prevention of diabetic foot. It will deal with the long-term effects on mother and child regarding • Use a variety of tools and intervention approaches that enhance metabolic and cardiovascular disease. It will also deal with diabetes patients’ ability to manage their diabetes and their health in Learning Objectives Learning Objectives in children, from type 1 to the emerging issue of type 2 diabetes in general After attending a session in the Diabetic Complications stream the After attending a session in the Diabetic Foot stream the participant children. • Work with patients, their families, and communities to improve participant will be able to: will be able to: understanding of diabetes, its prevention and care, and the quality • Understand the epidemiology, physiopathology, diagnosis, • Identify the importance of prevention of diabetic foot and to be Learning Objectives of life of those with diabetes prevention and treatment of the complication developed in the able to detect the risk factors for it After attending a session in the Diabetes in Women and Children • Address a variety of specific challenges in diabetes prevention and session • Understand the latest innovations in diabetic foot treatment stream the participant will be able to: care worldwide • Decide how to individualise the diagnostic, prevention and • Better understand the impact of diabetic foot problems on patients, • Understand that hyperglycaemia in pregnancy (HIP) is one of treatment tools in the setting where he/she operates as healthcare their families and on the health system the most common medical conditions women encounter during practitioner • Use available resources to improve the outcome of patients with pregnancy • Define the appropriate moment to refer the patient to a level of diabetic foot greater complexity • Correctly plan the establishment of diabetic foot centres

14 15 PROGRAMME PREVIEW

Epidemiology and Public Health Programme Sessions

Description Debates This stream deals with the latest trends in diabetes and its Two opposing teams will defend and refute current topics to do with complications, the public health challenges being faced and how to diabetes. prevent them. Meet-the-Experts Learning Objectives Participants are given the opportunity to interact with one or more After attending a session in the Epidemiology and Public Health experts on a specific topic. stream the participant will be able to: • Recognise the crucial importance of continuing to work on Open Forums prevention and how to overcome modern challenges to metabolic Participants are given the chance to discuss a specific topic with a health panel of experts. • Describe how current epidemiological data can be used to help shape future policy and healthcare implementation Symposia • Translate successful strategies from projects presented into future Symposia will showcase the latest findings in diabetes research and prevention programmes current issues in therapy and education.

Living with Diabetes Teaching Lectures Recognised experts will give educational lectures on specific topics. Description This format will combine a lecture with a question and answer This stream provides the participant with the perspective of the section. person with diabetes and how the person with diabetes can have an impact on the diabetes epidemic. Workshops Specific topics will be discussed accompanied by practical Learning Objectives demonstrations, problem-solving or hands-on training sessions. After attending a session in the Living with Diabetes stream the participant will be able to: Oral Poster Presentations • Recognise the multiple aspects of living the best life possible with Poster authors discuss their findings with an audience during a diabetes dedicated session. • Understand some of the day-to-day challenges faced by people with diabetes Poster Displays • Identify technologies with potential for positive impact on diabetes A collection of selected abstracts will be displayed as posters. management • Be a powerful enabler of positive self-care.

16 17 PROGRAMME TOPIC OVERVIEW

Basic and Clinical Science • SGLT-2 inhibitors should be the first-line therapy for type 2 diabetes Neuropathy Diabetic Foot • Innovative insulin delivery and insulin clearance • Autonomic neuropathy Type 1 diabetes • Synergism through combination: which drugs should be used Prevention • The environmental impact that interacts with the genetic together? Retinopathy • Prevention: how to mobilise patient organisations predisposition for type 1 diabetes • New pharmacologic approaches to the treatments of type 2 diabetes • Challenges in diabetic retinopathy: what to do in low and middle • Organisations for educating patients • Cell replacement for type 1 diabetes • What do clinicians need to know about hypoglycaemia in clinical income countries? • Arresting autoimmune disease in type 1 diabetes: towards antigen- practice? Health workforce specific interventions • Clinical implications of emerging biomarkers in type 2 diabetes Cardiovascular disease • Educating health care providers in primary care • Latent Autoimmune Diabetes in Adults (LADA) • Information and communications technologies in diabetes • Impact of antihyperglicemic therapy in cardiovascular disease: past, • Certification of physicians and community health workers management present, future and actual translation into clinical practice • Certification of medical centres providing outpatient and inpatient care Basic research • Should there be an entirely new way to classify diabetes? • Non-invasive methods for detecting cardiovascular diseases in • Comparative study of genetics risks factors of type 2 diabetes • Diabetes and cancer patients with diabetes Treatment mellitus and related traits in African, American, Asian and European • Diabetes in elderly • Diagnosis and treatment of cardiovascular diseases and • Footwear for people with diabetes and people with symptoms of populations microvascular impact in women with diabetes: first world and low diabetic foot • Precision medicine: the many ways in which genomics might, or Cardiovascular outcome trials of glucose lowering agents and middle income countries - are there differences? • What next after amputation? Prostheses in different settings might not, optimise diabetes prevention and treatment • Infection • Is epigenetics the missing link between the environment, our NAFLD in diabetes and the metabolic syndrome: clinical guidelines Other complications • Peripheral arterial disease in people with diabetes genome and type 2 diabetes and complications? and practical recommendations • Forgotten complications of diabetes • The role of the brain in metabolic regulation • Non-alcoholic fatty liver disease Research into diabetic foot • Metabolic signals that control glucose homeostasis Post transplantation diabetes and its management • Diabetes and cognitive decline • Novel regulators of insulin resistance • Euglycemic ketoacidosis Diabetes in Society and Culture • Mitochondria and energy metabolism in obesity and diabetes: a Science of Diabetic Complications new therapeutic target Diabetes and Disasters Diabetes and sustainable development • Interactions between gut microbes: bacteria, metabolites and Vascular disease • Health policies in all policies for primary and secondary prevention regulation of glucose homeostasis • Non-severe hypo and macrovascular outcomes: does it damage? Diabetes and natural disasters of diabetes • Lessons learned on diabetes pathogenesis based on human • Endothelial damage attributable to hyperglycemia: is it similar in • Prevention based on science of improvement pancreas/islets micro and macrovasculature? Diabetes and man-made disasters: conflicts and war • Real-life evidence in diabetes • Pathophysiology of diabetes in different populations: basic to • Prediabetes and macrovascular impact • Diabetes registries and big data clinical perspectives • Gestational diabetes and micro and microvascular impact Preparing for disasters • Diabetes and public-private partnerships • Glucagon in physiology and pathophysiology Nephropathy The role of humanitarian organisations Disenfranchised and vulnerable populations Clinical research and management • Diabetic nephropathy: from the beginning • Impact of income, education, gender, age, social class on diabetes • Obesity management for the treatment of type 2 diabetes: low- • Biomarkers in the early diagnosis of diabetic nephropathy Lessons from the past • Diabetes in migrants (not refugees) calorie and very low-calorie diet, weight loss medications, bariatric/ • Combining ACEI with ARBs in early diabetic nephropathy: what is • Insulin for Life metabolic surgery - which treatment for which patient? the verdict? • Life For A Child • Incretins and their pleitropic actions • The role of service organisations and charities

18 19 Advocacy Education and Integrated Care National diabetes plans Hypoglycemia from the point of view of the person with • Ethics and diabetes diabetes • Discrimination Intervention and patient education strategies and challenges Epidemiology and Public Health • How does hypoglycemia feel? • Integration of people with diabetes in the society: the impact of • Low carbohydrate diet • Fear and impact on quality of life cultural backgrounds • Preventing hospitalisations Epidemiological studies • Epidemiology: observation studies Children and young adults with diabetes Health anthropology Professional education and training • Current status of risk factor studies • Transition from pediatric to adult care • Early diagnosis of type 1 diabetes and prevention of diabetic • Including education on comorbidities • Global increase in type 1 diabetes: new estimates • Parental acceptance of diagnosis ketoacidosis according to different societies and cultures • Type 2 diabetes: MENA observational study • Diabetes foot care according to different societies and cultures Broadening and integrating care Diabetes advocacy: nothing about us without us • Food and beliefs • Community health workers, peer support, health coaches, etc. Diabetes prevention • The symbiosis between diabetes organisations and people with • Traditional healers • Community approaches to care • Prevention of gestational diabetes and complications diabetes • Diabetes and Ramadan • Integration of primary and specialty care with community resources • Prevention trials • Global examples (Africa, South Asia, USA) • Prevention in the workplace and productivity Social and economic factors influencing epigenetics “High tech” and information technology, Diabetes technology: digital health and mobile tools and related innovations Healthcare • Apps and tools: a landscape overview Camps • Social media • Reimbursement of prevention services • Culturally appropriate digital tools • Big data analyses and applications • Cost issues relating to complications • We’re not waiting vs. why we are waiting Diabetes in Women and Children • Digital health, including mobile and eHealth applications • Criteria to start pharmacotherapy Thriving with diabetes Diabetes in women Interventions for special populations Type 1 diabetes in young adults • A long happy life with diabetes • Reproduction issues in women with diabetes: infertility, • Immigrant groups • Balancing diabetes: knowledge and temptations, fatigue and contraception and menopause • Indigenous groups Risk factors for gestational diabetes and type 2 diabetes motivation • Refugees Diabetes during pregnancy • Stigmatised ethnic minorities Complications The stigma of diabetes • Detection and diagnosis of the abnormal carbohydrate metabolism • Groups stigmatised by gender identity • Retinopathy, cardiovascular disease and dementia • Language matters: when speaking to and about people with diabetes during pregnancy • Low-income groups • Appropriate interventions • Management of diabetic pregnancy; medical nutritional therapy Efficacy trials and pharmacological therapy during pregnancy Integrating medical advances into routine care and practice Diabetes complications from the point of view of the person • Prevention of gestational diabetes in high risk individuals • Multi-pharmacy and the role of the pharmacist Genetics with diabetes • Gene-lifestyle interactions • The emotional fallout of a complication diagnosis Diabetes in children Quality of life and psychosocial well being • Genetic risk scores • Management of children and adolescents with type 1 or type 2 Diabetes and mental health diabetes National examples of progressive and integrated care Living with Diabetes • Distress • Diabulimia Prediction and prevention of type 2 diabetes and/or cadiometabolic Prevention Peer-to-peer support and education syndrome in mothers and their offspring • Emphasis on primary prevention • The perspective of the person with diabetes • Face to face vs. online peer support Community and policy • Inter-sectoral policies

20 21 22 23 CALL FOR ABSTRACTS

Abstract Submission

The IDF Congress 2017 welcomes original abstracts on subjects author per abstract. The same abstract CANNOT be submitted of your abstract. Categories are used for reviewing and indexing Selection and notification process relevant to the following 9 streams: multiple times by different submitting authors or by listing different purposes. • Selection: All submitted abstracts undergo a peer-review • Basic and Clinical Science presenting authors. An unlimited number of abstracts can be • Abstract title: The title is limited to 120 characters including process by an international panel of reviewers. Accepted abstracts • Science of Diabetic Complications submitted by an author. spaces and should be brief and relevant. Special characters should are selected for oral poster presentation or poster display. The • Diabetes and Disasters • Language: All abstracts must be submitted in English. Should NOT be used in your title but spelt out instead (e.g. α should be Programme Committee reserves the right to accept or reject any • Diabetic Foot English not be your first language, you may wish to have your written as alpha, β as beta). Only use standard abbreviations and submitted abstract and re-categorise any accepted abstract. The • Diabetes in Society and Culture abstract examined by a native English speaker prior to submission. generic drug names in the title. decision of the Programme Committee is final and irrevocable. • Diabetes in Women and Children • Accuracy of content: Submitted abstracts may be edited online • Authors: Only 12 authors and/or study groups can be listed. Only • Notification: Notice of acceptance or rejection of submitted • Education and Integrated Care up to the abstract submission deadline of 21 April 2017. Abstracts one institution can be entered per author. abstracts will be sent to the submitting authors by mid-July 2017. • Epidemiology and Public Health CANNOT be edited or revised in any way after the deadline. All • Abstract body: It is the responsibility of the submitting author to inform all other • Living with Diabetes accepted abstracts will be published as submitted by the authors. • The abstract structure is laid out under the headings authors of the status of the abstract. A submitting author may also The responsibility for the submission of an accurate and precise Background, Aims, Method, Results and Discussion. check their congress profile to see the status of the abstract. Guidelines abstract lies solely with the authors. • Font size and style will be automatically configured by the • Author Registration: Presenting authors of accepted abstracts Online abstract submission opens on 1 February and closes • Originality of abstracts: Work published elsewhere before 4 system. MUST register for the congress by 15 September 2017. If the entire on 21 April 2017. December 2017 should NOT be submitted to the IDF Congress • Tables will be accepted in the submission field and count registration fee is not paid by the deadline, the abstract will be 2017. However, previously published work can be resubmitted towards the word limit. The word deduction for tables is not automatically withdrawn and will NOT be presented or published. • Submission mode: Abstract submission is only possible online at provided there are new methods and/or findings. fixed and will be generated by the word count shown below To benefit from the early registration rate, authors must register by www.idf.org/congress. Abstracts submitted by post, fax or email will • Disclosure of interests: Any financial relationships with the submission field. Graphs, figures and photographs are NOT 18 August 2017. NOT be accepted. The online abstract submission module will NOT commercial entities related to the authors or products and allowed. • Presenting author changes: Changes to the presenting author be available after 21 April 2017. processes described in the work must be correctly disclosed. • The length of the abstract is limited to 700 words. Only the for an abstract need to be requested using the appropriate form • IDF congress profile: In order to submit an abstract, a congress • Regulatory approval: The submitting author confirms that local abstract body and any inserted tables count towards this word which can be found on the congress website www.idf.org/congress. profile must be created giving access to the online abstract regulatory approval has been obtained as required by local laws. limit. The word count displayed beneath the submission field is submission module. The submitting author must ensure accurate • Author consent: The submitting author declares all authors have final and indisputable. contact details are entered. One or more abstracts can be read and approved the submitted work. • Only commonly accepted abbreviations should be used. Late-Breaking Abstract Policy submitted by logging into this congress profile. • Copyright transfer: Authors must attest that their submitted Treatment groups or drug names should NOT be abbreviated. • Submitting author / presenting author: If the submitting work does not infringe any copyright legislation. Copyright for Less widely recognised abbreviations may be used if introduced Please note that the IDF Congress 2017 will not be accepting author is not also the presenting author, the submitting the publication of abstracts is automatically transferred to the on first usage. late-breaking abstracts. All abstracts must be submitted during the author is responsible for informing the presenting author of all International Diabetes Federation upon submission and acceptance • Only approved and generic (non-proprietary) drug names regular submission period starting on 1 February and ending on 21 communications received regarding the abstract. of the regulations within the online submission module. should be used. April 2017. • Presenting author registration: The presenting author must be For rejected abstracts, the copyright reverts back to the authors. • Do NOT enter the title, authors, or grant information into the registered by 15 September 2017. If the presenting author is not abstract body submission field but include any references at registered by 15 September 2017 their abstract will be REMOVED Instructions the end of the abstract. from the programme. To benefit from the early registration rate, the • Category & stream: There are various categories that have presenting author must register by 18 August 2017, after that date been defined for the abstract programme within the nine the standard rate will apply. streams. Ensure that you select the MOST relevant stream and • Number of submissions: There can only be ONE presenting then place it in the category which BEST describes the content

24 25 Abstract Categories • Incretin therapies Continuing Medical Education (CME) • Inflammation • Bariatric surgery • Insulin action Applications for Continuing Medical Education (CME) accreditation • Blood pressure • Insulin secretion, beta-cell function for physicians and other healthcare professionals will be presented • Care delivery • Insulin therapy and devices to the national accreditation body and the European Accreditation • Cognition, psychology and behaviour • Islets - beta-cell biology Council for Continuing Medical Education (EACCME). EACCME • Comorbidities • Lipids and lipoproteins credits are recognised by the American Medical Association towards • Complications • Living with diabetes the Physician’s Recognition Award (PRA). It is expected that the IDF • Complications - cardiovascular disease • Microbial flora Congress 2017 will be accredited with between 20 and 22 hours of • Complications - eye • Nutrition and diet CME credits. CME certificates will be available to print in the congress • Complications - foot • Obesity centre and online as of Thursday 7 December 2017. • Complications - kidney • Oral glucose-lowering therapies • Complications - nerve • Physical activity • Complementary medicine • Pregnancy and gestational diabetes • Diabetes advocacy • Primary and secondary prevention • Diabetes and infections • Rights and responsibilities of people with diabetes • Diabetes and the brain • Screening and risk stratification • Diabetes organisations • Stem cell therapy • Diabetes education • Telecommunication, internet and social media • Diabetes epidemiology • Transplantation - islet and pancreas • Diabetes in childhood and adolescence • Type 1 diabetes • Diabetes in Indigenous groups • Type 2 diabetes • Diabetes in rural areas • Diabetes in the elderly and vulnerable populations • Diabetes management IDF Congress Grant • Diagnosis and classification • Discrimination and diabetes The IDF congress grant aims to provide 100 people from around the • Education and development for healthcare professionals world with the opportunity to attend the congress and present their • Engagement of people with diabetes work. • Environment and lifestyles Grant applicants should: • Epigenetics • Be no more than 35 years of age at the time of the congress • Genetics of diabetes • Submit an abstract to be approved by the Programme Committee • Glucagon • Fill in the online grant application form • Guidelines, clinical care • Health services research Accepted grantees are offered free registration, up to 4 congress • Health workforce nights’ accommodation and an economy return flight to Abu Dhabi, • Healthcare financing UAE. • Hypoglycaemia • In utero environment Online grant submission opens on 1 February and closes on • Incretin physiology and pathophysiology 28 April 2017.

26 27 REGISTRATION

Individual Registration Group Registration

• Participants are required to register online at www.idf.org/congress as of January 2017. A valid email • Group registration is available for groups of at least 10 participants. One contact person should coordinate with the Congress Secretariat. address will be required. • The group rate is at the regular rate per person. New group rate discounts are now available. • Registration and corresponding payment should be received by 13 November 2017. • All registration information will be sent to the group contact person, who will then be responsible for distribution to the group. • After that date, the online registration system will no longer be available and registration will only be • A special module for group registration is accessible online at www.idf.org/congress. possible on site. • The group contact person will receive detailed instructions on how to collect the group’s registration badges. • Registration at the on-site rate will be possible during the congress (4 December - 8 December 2017). Day rates will also be available on site. Payment

Registration opening hours Payment should preferably be made by credit card (Eurocard/Mastercard, VISA or American Express). Please indicate the card owner’s name (as Days Hours shown on the card) and the expiry date. Monday 4 December 07.00 – 18.00 Payments can also be done by direct bank transfer without charges to the beneficiary: Tuesday 5 - Thursday 7 December 07.00 – 18.00 • Beneficiary name: IDF Friday 8 December 07.00 – 11.00 • Account name: IDF Congress • Account number / IBAN: BE67 6451 4103 3587 • Swift code / Routing: BIC JVBABE 22 Registration rate structure • Bank name: Bank: J. Van Breda & Co (all indicated amounts are in EUR) • Bank address: Vlaanderenstraat 53, 9000 Gent, . Category Early rate Standard rate Onsite rate Day rate Until 18 Aug 2017 From 19 Aug 2017 4-8 Dec 2017 4-8 Dec 2017 The name and address of the participant should be clearly stated on the bank transfer. Regular rate 550 880 990 330 Please bear in mind that an international bank transfer can take up to 10 days to reach our account. Reduced rate (1) 400 600 700 330 If payment is not received by the corresponding deadline (early or standard registration), the subsequent rate will automatically apply. Student (2) 110 110 110 110 Low-income economies (3) 220 330 440 165 Name change/cancellation for individual registrants All name changes and cancellation requests must be done in writing by email. No changes or cancellations will be accepted by telephone. A name (1) This reduced rate is available for healthcare professionals other than medical doctors, and for medical doctors 35 years or younger at the time of the congress. Applicants for this rate must send a copy of their ID/passport (for young change for a confirmed registration will be subject to an administrative fee of 50 EUR per participant. doctors) and professional ID for healthcare professional to [email protected]. Cancellation of a confirmed registration will be subject to an administrative fee of 50 EUR per participant. Please note that if you cancel after 13 (2) This reduced rate is available for participants who are students at the time of the congress. This rate is not applicable November 2017, no refund will be possible. to persons holding a post-doctorate degree. Applicants for the student rate must send their valid student ID to [email protected]. Refunds (3) This reduced rate is available for participants who are citizens AND residents of a low-income country as per World Bank classification. Please note that any applicable refund will be reimbursed after the congress.

28 29 ACCOMMODATION, TRAVEL AND VISA

Accommodation

International Conference Services (ICS) is the official housing bureau for the IDF Congress 2017 and will offer assistance with the coordination of housing requests. A wide variety of hotels have been secured in the heart of Abu Dhabi and within walking distance to the congress venue.

Bookings

All sponsors, exhibitors and delegates are encouraged to book at the official IDF congress 2017 hotels to benefit from special rates.

IDF Congress Housing Bureau Contact: Tel: +1 720 325 2944 Fax: +1 604 681 2153 Email: [email protected] Groups bookings (10 or more): [email protected] Tel: +1 236 521 0014

30 31 Single Occupancy Rate Single Occupancy Rate Hotels Distance from ADNEC Star Rating Hotels Distance from ADNEC Star Rating (Incl. Breakfast & HS Internet) (Incl. Breakfast & HS Internet) Zone 1 – Corniche Area Zone 5 – Khor Al Maqta Area Crowne Plaza Hotel 20 minute drive 5 AED 740 Armed Forces Officer's Club & Hotel 10 minute drive 5 AED 511 Hala Arjaan Hotel 20 minute drive 4 TBC Fairmont Bab Al Bahr Hotel 15 minute drive 5 AED1,200 Hilton International Hotel Abu Dhabi 25 minute drive 5 TBC Ibis Gate Hotel 10 minute drive 3 TBC Khalidiya Palace Rayhaan 20 minute drive 5 TBC Novotel Abu Dhabi Gate Hotel 10 minute drive 4 TBC Le Royal Meridien Abu Dhabi 20 minute drive 5 AED 650 Shangri-La Hotel - Qaryat Al Beri 15 minute drive 5 AED 1,155 Corniche Hotel 20 minute drive 5 AED 650 The Ritz Carlton Abu Dhabi 10 minute drive 5 TBC Ramada Hotel 20 minute drive 4 AED 480 Traders Hotel - Qaryat Al Beri 12 minute drive 4 AED 550 Sheraton Abu Dhabi Hotel 20 minute drive 5 AED 740 Zone 6 – Eastern Corniche Area Sofitel Abu Dhabi Corniche 20 minute drive 5 AED 917 Holiday Inn Abu Dhabi 7 minute drive 4 AED 911 Southern Sun Hotel 20 minute drive 4 AED 860 Novotel Abu Dhabi Al Bustan 7 minute drive 4 TBC St.Regis Abu Dhabi Hotel 20 minute drive 5 AED 960 Park Rotana Hotel 9 minute drive 5 TBC Zone 2 – Metropolitan City Area Zone 7 – Al Bateen Area 25 minute drive 5 TBC Bab Al Qasr 18 minute drive 5 AED 900 Centro Al Manhal 15 minute drive 3 TBC Grand Hyatt 30 minute walk 5 AED 790 City Seasons Al Hamra Hotel 20 minute drive 4 TBC Intercontinental Hotel Abu Dhabi 20 minute drive 5 TBC Jumeirah at Etihad Towers 20 minute drive 5 TBC Courtyard By Marriot, World Trade Centre 20 minute drive 4 AED 570 Zone 8 – Al Zahiyah Dusit Thani Abu Dhabi Hotel & Apartments 15 minute drive 5 AED 375 Le Meridien Abu Dhabi Hotel 25 minute drive 4 AED 613 Grand Mercure Majilis 20 minute drive 5 TBC Zone 12 – Yas Island Holiday Inn Abu Dhabi Downtown 20 minute drive 4 TBC Centro Yas Island 25 minute drive 3 TBC Marriott Downtown 20 minute drive 4 AED 641 Crowne Plaza Hotel Yas Island 25 minute drive 4 TBC Royal Rose Hotel 20 minute drive 5 AED 550 Park Inn Yas Island Hotel 25 minute drive 3 AED 660 Zone 3 – ADNEC Area Radisson Blu Hotel Yas Island 25 minute drive 4 AED 760 Aloft Abu Dhabi Hotel 3 minute walk 4 AED 615 Yas Island Rotana 25 minute drive 4 TBC Centro Capital Centre 3 minute walk 3 AED 911 Zone 13 – Khalifa City Hyatt Capital Gate, Abu Dhabi Hotel 5 minute walk 5 AED1,413 Premier Inn Hotel Abu Dhabi International Airport 25 minute drive 3 TBC Premier Inn Abu Dhabi Capital Centre 5 minute walk 3 AED 542 The Westin Abu Dhabi 20 minute drive 5 AED 586 Zone 4 – Zayed Sports City Area Hilton Capital Grand Abu Dhabi 5 minute drive 5 TBC • AED = United Arab Emirate Dirham • TBC = rates still to be confirmed • All rates are subject to applicable taxes and fees: currently at 20% (10% service charge fee, 6% tourism fee, 4% municipality fee) plus an additional 15 AED per room per night 32 • All Abu Dhabi hotels require valid photo ID upon check-in (Passport, GCC ID, UAE Drivers License or Emirates ID accepted) 33 Travel Other Countries - Prearranged Visa Visa Application Processing Times

Esser Travel is the official travel agency for the IDF Congress 2017 and Nationals of countries not included in the Visa on Arrival list will Please ensure that you give yourself enough time for your visa will offer assistance with the coordination of travel requests. require a prearranged visa to enter the United Arab Emirates. application to be approved. IDF Congress Travel Agency Contact: If the online application link mentioned above is used, then the T: + 30 21 09632404 How to Start an Application processing time for an application is typically 3-5 UAE working days F: +30 21 09632589 (Sunday to Thursday). Email: [email protected] The easiest way to obtain a UAE Visa is to apply online at www.ttsuaevisas.com/idf2017 Whether an application is approved or not is at the sole discretion Visa of the UAE Immigration Department and it is no other party’s • Fill out a simple, self-explanatory application form responsibility if the visa is declined. Fees paid in regards to approved Please see the following information to check if you can obtain a visa • Keep scanned copies of all the required documents ready or declined applications cannot be refunded. on arrival or if you require a prearranged visa to enter the United Arab • Upload the documents as explained Emirates. • Pay the corresponding visa fee online through the secure link Issuance of a visa or approval on the visa application does not in any way guarantee the guest the right to enter UAE. The entry is at the Visa on Arrival A confirmation e-mail will be sent to you when your application has sole discretion of the immigration officer at the airport. been received. Citizens of eligible countries/regions are allowed to enter the UAE The progress of your application can be checked online. without a visa prior to arrival: After communication from UAE Immigration, an email will be sent to • Passport should be valid for a minimum period of 6 months you with the corresponding decision. Successful applicants will then • Type of Visa: 30 days Tourist visa receive their visas by email. • Duration of stay: 30 Days including the entry and the departure After receiving your visa, you must print it out and carry it with you for days boarding the airplane • Number of entries: Only single entry is permitted Alternatively, you can apply for a visa through your nearest UAE • An eye scan will be taken at the immigration desk in the airport embassy. • Fee: Free of charge • Only normal passports can be used for visa applications (i.e. no Notes: Diplomatic Passports) • Passport should be valid for a minimum period of 6 months Countries Eligible for Visa on Arrival • Type of Visa: 30 days Tourist visa • Entry into UAE: Within 60 days from and including the visa issuance Andorra, Australia, Austria, Belgium, Brunei, , Canada, , day , , Denmark, , Finland, , Germany, • Duration of stay: 30 Days including the entry and the departure days , Hong Kong, , Iceland, , Italy, Japan, , • Number of entries: Only single entry is permitted Liechtenstein, Lithuania, , , Malta, , • An eye scan will be taken at the Immigration desk in the airport Netherlands, New Zealand, , Poland, , Romania, San • Fee: AED370 / US$100 Marino, , , , Slovenia, , Spain, • Cancellation Charge: AED150 / US$41 per visa , , United Kingdom, United States of America, • Only normal passports can be used for visa applications (i.e. no Vatican City. *GCC citizens do not need a visa to enter the UAE. Diplomatic Passports)

34 35 CONTACT IDF 2017: A HEALTHY CONGRESS

All enquiries and correspondence in relation to the congress should be directed to: Let’s turn our words into action and make this congress the healthiest yet!

International Diabetes Federation Housing The 5K@IDF Chaussée de La Hulpe 166 [email protected] B- 1170 Brussels T: [+1] 720-325-2944. Join us on Wednesday 6 December for the 5K@IDF! Help raise awareness about the importance of a healthy lifestyle in preventing type 2 diabetes Belgium Group accommodation (10 rooms or more): and managing all types of diabetes. T: +32 2 543 16 31 [email protected] Participation is free for all. See www.idf.org/congress for more information. F: +32 2 403 08 30 T: [+1] 236 521 0014. www.idf.org/congress Walk the talk Travel General enquiries [email protected] Forget about the elevators and escalators and take a step for diabetes. Your body will appreciate it! [email protected] T: + 30 21 09632404 Benefit from coffee & lunch breaks and walk the poster area or enjoy the e-poster presentations, standing ovations welcome!

Industry relations Media Food for thought [email protected] [email protected] T: +32 2 543 16 33 A varied diet is a cornerstone of health. A choice of healthy meals and snacks will be available at reasonable prices from the food outlets Join the conversation! throughout the congress venue. Programme and abstracts Find us on & Twitter [email protected] www.facebook.com/intdiabetesfed Move those muscles @IntDiabetesFed Registration #IDF2017 Increase your activity by taking part in organised fitness ball exercise sessions throughout the day in the exhibition hall. If you miss a session, feel [email protected] free to use the area at any time to stretch and work those muscles!

36 37 SANOFI FOCUSED ON PATIENTS’ NEEDS Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to making a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.

More information on www.sanofi.com

Sans titre-1 1 15/07/2016 17:10:39